Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3388)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$525.02
Total Value
$459.92K
Shares Held After
330,626
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,074
Price
$524.04
Total Value
$562.82K
Shares Held After
331,502
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,367
Price
$523.15
Total Value
$715.15K
Shares Held After
332,576
% of Holdings
0.4%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$34.95
Total Value
$6.99M
Shares Held After
1,613,063
% of Holdings
11.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
7,798
Price
$5.00
Total Value
$38.99K
Shares Held After
383,456
% of Holdings
2.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$87.53
Total Value
$60.22K
Shares Held After
216,438
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
16,667
Price
$25.74
Total Value
$429.04K
Shares Held After
85,696
% of Holdings
16.3%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,000
Price
$20.00
Total Value
$20.00K
Shares Held After
51,776
% of Holdings
1.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7
Price
$42.73
Total Value
$299.14
Shares Held After
537,607
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,203
Price
$42.11
Total Value
$92.76K
Shares Held After
537,614
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
5,388
Price
$26.04
Total Value
$140.32K
Shares Held After
3,586,796
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
256,072
Price
$25.50
Total Value
$6.53M
Shares Held After
3,592,184
% of Holdings
6.7%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
1,600
Price
$87.53
Total Value
$140.05K
Shares Held After
167,919
% of Holdings
0.9%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.62
Total Value
$20.43K
Shares Held After
5,609,202
% of Holdings
0.0%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
378
Price
$55.91
Total Value
$21.14K
Shares Held After
133,215
% of Holdings
0.3%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
622
Price
$55.54
Total Value
$34.55K
Shares Held After
133,593
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
244
Price
$55.96
Total Value
$13.66K
Shares Held After
133,215
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
756
Price
$55.52
Total Value
$41.97K
Shares Held After
133,459
% of Holdings
0.6%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
4,415
Price
$55.93
Total Value
$246.94K
Shares Held After
453,247
% of Holdings
1.0%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
11,783
Price
$55.52
Total Value
$654.13K
Shares Held After
457,662
% of Holdings
2.5%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.44
Total Value
$17.20K
Shares Held After
652,000
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$535.04
Total Value
$21.40K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
957
Price
$533.53
Total Value
$510.59K
Shares Held After
324,483
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,529
Price
$532.38
Total Value
$814.00K
Shares Held After
325,440
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,836
Price
$531.65
Total Value
$976.11K
Shares Held After
326,969
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,121
Price
$530.49
Total Value
$594.67K
Shares Held After
328,805
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,797
Price
$529.75
Total Value
$951.96K
Shares Held After
329,926
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$528.51
Total Value
$343.53K
Shares Held After
331,723
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
890
Price
$527.14
Total Value
$469.15K
Shares Held After
332,373
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$525.81
Total Value
$357.55K
Shares Held After
333,263
% of Holdings
0.2%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$80.87
Total Value
$606.52K
Shares Held After
377,820
% of Holdings
1.9%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,188
Price
$3.37
Total Value
$10.74K
Shares Held After
647,000
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
41,319
Price
$9.99
Total Value
$412.78K
Shares Held After
17,283,802
% of Holdings
0.2%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
6,100
Price
$12.02
Total Value
$73.32K
Shares Held After
206,672
% of Holdings
2.9%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
7,000
Price
$12.02
Total Value
$84.14K
Shares Held After
38,300
% of Holdings
15.5%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
12,500
Price
$11.71
Total Value
$146.43K
Shares Held After
702,770
% of Holdings
1.7%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,000
Price
$3.73
Total Value
$11.19K
Shares Held After
643,812
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$535.03
Total Value
$60.46K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
630
Price
$534.39
Total Value
$336.67K
Shares Held After
324,556
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,818
Price
$533.20
Total Value
$969.36K
Shares Held After
325,186
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,719
Price
$532.27
Total Value
$1.45M
Shares Held After
327,004
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,115
Price
$531.10
Total Value
$592.18K
Shares Held After
329,723
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,285
Price
$530.45
Total Value
$1.21M
Shares Held After
330,838
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
820
Price
$528.72
Total Value
$433.55K
Shares Held After
333,123
% of Holdings
0.2%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,100
Price
$12.88
Total Value
$14.17K
Shares Held After
5,607,702
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$39.80
Total Value
$59.70K
Shares Held After
116,731
% of Holdings
1.3%
Shares
2,616
Price
$1.21
Total Value
$3.17K
Shares Held After
3,280,272
% of Holdings
0.1%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
12,500
Price
$11.58
Total Value
$144.74K
Shares Held After
715,270
% of Holdings
1.7%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
7,783
Price
$2.95
Total Value
$22.94K
Shares Held After
584,375
% of Holdings
1.3%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
9,475
Price
$2.95
Total Value
$27.93K
Shares Held After
1,731,869
% of Holdings
0.5%
Showing 451–500 of 3388 transactions (page 10 of 68)